While there was a significant increase in the tumor-infiltrating CD8+ T cells in the mice bearing Renca-Control tumors after Lm-LLO-CD105A treatment as expected (Figure 7B), CTL infiltration was not increased in mice bearing Renca-CD105KD tumors (Figure 7D). Here, CD8A is linked to neoplasm.